Načítá se...
Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
We performed post-mortem studies on two patients with advanced Parkinson’s disease 8 and10 years following AAV2-neurturin (CERE120) gene therapy, the longest post-mortem trophic factor gene therapy cases reported to date. CERE120 was delivered to the putamen bilaterally in one case (10 years post-su...
Uloženo v:
| Vydáno v: | Brain |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7089653/ https://ncbi.nlm.nih.gov/pubmed/32203581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|